<--- Back to Details
First PageDocument Content
Gilead Sciences / Pharmacology / Non-nucleoside reverse transcriptase inhibitors / Organofluorides / Bristol-Myers Squibb / Reverse-transcriptase inhibitor / ATC code J05 / Emtricitabine / Tenofovir / Chemistry / Organic chemistry / Fixed dose combination
Date: 2015-03-19 08:38:15
Gilead Sciences
Pharmacology
Non-nucleoside reverse transcriptase inhibitors
Organofluorides
Bristol-Myers Squibb
Reverse-transcriptase inhibitor
ATC code J05
Emtricitabine
Tenofovir
Chemistry
Organic chemistry
Fixed dose combination

STATE OF TENNESSEE DEPARTMENT OF HEALTH Ryan White Part B Program HIV DRUG ASSISTANCE PROGRAM (HDAP) FORMULARY

Add to Reading List

Source URL: tn.gov

Download Document from Source Website

File Size: 71,50 KB

Share Document on Facebook

Similar Documents

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

DocID: 1rqYi - View Document

Microsoft WordDOCX

Microsoft WordDOCX

DocID: 1rnqZ - View Document

Beilage 1: Arzneimittelmonographien

Beilage 1: Arzneimittelmonographien

DocID: 1rinj - View Document

SAFETY DATA SHEET Page 1 of Total 6 Date of Issue: August 2016 SDS No. FMC/RAD/1  SECTION 1

SAFETY DATA SHEET Page 1 of Total 6 Date of Issue: August 2016 SDS No. FMC/RAD/1 SECTION 1

DocID: 1rdYu - View Document

imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib

imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib

DocID: 1rdbp - View Document